Kate Jongbloed1, Margo E Pearce1, Sherri Pooyak1, David Zamar1, Vicky Thomas1, Lou Demerais1, Wayne M Christian1, Earl Henderson1, Richa Sharma1, Alden H Blair1, Eric M Yoshida1, Martin T Schechter1, Patricia M Spittal2. 1. School of Population and Public Health (Jongbloed, Sharma, Blair, Schechter, Spittal), Department of Chemical and Biological Engineering (Zamar), and Faculty of Medicine, Division of Gastroenterology (Yoshida), The University of British Columbia; Canadian HIV Trials Network (Pearce); Canadian Aboriginal AIDS Network (Pooyak [Cree]); The Cedar Project, BC Children's Hospital Research Institute (Thomas [Wuikinuxv Nation]), BC Children's Hospital; Vancouver Native Health Society (Demerais [Cree, Métis]), Vancouver, BC; Splatsin te Secwepemc (Christian [Splatsin te Secwepemc]); Department of First Nations Studies (Henderson [Cree, Métis]), University of Northern British Columbia, Prince George, BC; Division of Gastroenterology (Yoshida), Vancouver General Hospital, Vancouver, BC. 2. School of Population and Public Health (Jongbloed, Sharma, Blair, Schechter, Spittal), Department of Chemical and Biological Engineering (Zamar), and Faculty of Medicine, Division of Gastroenterology (Yoshida), The University of British Columbia; Canadian HIV Trials Network (Pearce); Canadian Aboriginal AIDS Network (Pooyak [Cree]); The Cedar Project, BC Children's Hospital Research Institute (Thomas [Wuikinuxv Nation]), BC Children's Hospital; Vancouver Native Health Society (Demerais [Cree, Métis]), Vancouver, BC; Splatsin te Secwepemc (Christian [Splatsin te Secwepemc]); Department of First Nations Studies (Henderson [Cree, Métis]), University of Northern British Columbia, Prince George, BC; Division of Gastroenterology (Yoshida), Vancouver General Hospital, Vancouver, BC spittal@sm.hivnet.ubc.ca.
Abstract
BACKGROUND: Young Indigenous people, particularly those involved in the child welfare system, those entrenched in substance use and those living with HIV or hepatitis C, are dying prematurely. We report mortality rates among young Indigenous people who use drugs in British Columbia and explore predictors of mortality over time. METHODS: We analyzed data collected every 6 months between 2003 and 2014 by the Cedar Project, a prospective cohort study involving young Indigenous people who use illicit drugs in Vancouver and Prince George, BC. We calculated age-standardized mortality ratios using Indigenous and Canadian reference populations. We identified predictors of mortality using time-dependent Cox proportional hazard regression. RESULTS: Among 610 participants, 40 died between 2003 and 2014, yielding a mortality rate of 670 per 100 000 person-years. Young Indigenous people who used drugs were 12.9 (95% confidence interval [CI] 9.2-17.5) times more likely to die than all Canadians the same age and were 7.8 (95% CI 5.6-10.6) times more likely to die than Indigenous people with Status in BC. Young women and those using drugs by injection were most affected. The leading causes of death were overdose (n = 15 [38%]), illness (n = 11 [28%]) and suicide (n = 5 [12%]). Predictors of mortality included having hepatitis C at baseline (adjusted hazard ratio [HR] 2.76, 95% CI 1.47-5.16), previous attempted suicide (adjusted HR 1.88, 95% CI 1.01-3.50) and recent overdose (adjusted HR 2.85, 95% CI 1.00-8.09). INTERPRETATION: Young Indigenous people using drugs in BC are dying at an alarming rate, particularly young women and those using injection drugs. These deaths likely reflect complex intersections of historical and present-day injustices, substance use and barriers to care.
BACKGROUND: Young Indigenous people, particularly those involved in the child welfare system, those entrenched in substance use and those living with HIV or hepatitis C, are dying prematurely. We report mortality rates among young Indigenous people who use drugs in British Columbia and explore predictors of mortality over time. METHODS: We analyzed data collected every 6 months between 2003 and 2014 by the Cedar Project, a prospective cohort study involving young Indigenous people who use illicit drugs in Vancouver and Prince George, BC. We calculated age-standardized mortality ratios using Indigenous and Canadian reference populations. We identified predictors of mortality using time-dependent Cox proportional hazard regression. RESULTS: Among 610 participants, 40 died between 2003 and 2014, yielding a mortality rate of 670 per 100 000 person-years. Young Indigenous people who used drugs were 12.9 (95% confidence interval [CI] 9.2-17.5) times more likely to die than all Canadians the same age and were 7.8 (95% CI 5.6-10.6) times more likely to die than Indigenous people with Status in BC. Young women and those using drugs by injection were most affected. The leading causes of death were overdose (n = 15 [38%]), illness (n = 11 [28%]) and suicide (n = 5 [12%]). Predictors of mortality included having hepatitis C at baseline (adjusted hazard ratio [HR] 2.76, 95% CI 1.47-5.16), previous attempted suicide (adjusted HR 1.88, 95% CI 1.01-3.50) and recent overdose (adjusted HR 2.85, 95% CI 1.00-8.09). INTERPRETATION: Young Indigenous people using drugs in BC are dying at an alarming rate, particularly young women and those using injection drugs. These deaths likely reflect complex intersections of historical and present-day injustices, substance use and barriers to care.
Authors: Akm Moniruzzaman; Margo E Pearce; Sheetal H Patel; Negar Chavoshi; Mary Teegee; Warner Adam; Wayne M Christian; Earl Henderson; Kevin J P Craib; Martin T Schechter; Patricia M Spittal Journal: Int J Circumpolar Health Date: 2009-06 Impact factor: 1.228
Authors: Margo E Pearce; Wayne M Christian; Katharina Patterson; Kat Norris; Akm Moniruzzaman; Kevin J P Craib; Martin T Schechter; Patricia M Spittal Journal: Soc Sci Med Date: 2008-06 Impact factor: 4.634
Authors: Patricia M Spittal; Kevin J P Craib; Mary Teegee; Catherine Baylis; Wayne M Christian; A K M Moniruzzaman; Martin T Schechter Journal: Int J Circumpolar Health Date: 2007-06 Impact factor: 1.228
Authors: Azar Mehrabadi; Katharina Paterson; Margo Pearce; Sheetal Patel; Kevin J P Craib; Akm Moniruzzaman; Martin T Schechter; Patricia M Spittal Journal: Women Health Date: 2008
Authors: Kevin Jp Craib; Patricia M Spittal; Sheetal H Patel; Wayne M Christian; Akm Moniruzzaman; Margo E Pearce; Lou Demerais; Christopher Sherlock; Martin T Schechter Journal: Open Med Date: 2009-12-15
Authors: David Ortiz-Paredes; Afia Amoako; Taline Ekmekjian; Kim Engler; Bertrand Lebouché; Marina B Klein Journal: Front Public Health Date: 2022-06-24
Authors: Kate Jongbloed; Margo E Pearce; Vicky Thomas; Richa Sharma; Sherri Pooyak; Lou Demerais; Richard T Lester; Martin T Schechter; Patricia M Spittal Journal: JMIR Mhealth Uhealth Date: 2020-07-27 Impact factor: 4.773
Authors: Meaghan Thumath; David Humphreys; Jane Barlow; Putu Duff; Melissa Braschel; Brittany Bingham; Sophie Pierre; Kate Shannon Journal: Int J Drug Policy Date: 2020-10-29
Authors: Margo E Pearce; Kate Jongbloed; Sherri Pooyak; Wenecwtsin M Christian; Maaxswxw Gibuu White Wolf Mary Teegee; Nadine R Caron; Victoria Thomas; Earl Henderson; David Zamar; Eric M Yoshida; Martin T Schechter; Patricia M Spittal Journal: BMJ Open Date: 2021-07-08 Impact factor: 2.692